SES - Delayed Quote SGD

Haw Par Corporation Limited (H02.SI)

9.87 +0.02 (+0.20%)
At close: 5:07 PM GMT+8
Loading Chart for H02.SI
DELL
  • Previous Close 9.85
  • Open 9.80
  • Bid 9.86 x --
  • Ask 9.86 x --
  • Day's Range 9.80 - 9.89
  • 52 Week Range 9.11 - 10.22
  • Volume 71,900
  • Avg. Volume 69,678
  • Market Cap (intraday) 2.185B
  • Beta (5Y Monthly) 0.41
  • PE Ratio (TTM) 10.07
  • EPS (TTM) 0.98
  • Earnings Date Feb 26, 2024
  • Forward Dividend & Yield 0.40 (4.06%)
  • Ex-Dividend Date May 3, 2024
  • 1y Target Est --

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties. In addition, it provides family and tourist oriented leisure activities primarily in the form of oceanariums. Further, the company is involved in the property development services; letting out of office spaces; and management support services. Haw Par Corporation Limited was incorporated in 1969 and is based in Singapore.

www.hawpar.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: H02.SI

Performance Overview: H02.SI

Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

H02.SI
1.23%
STI Index
1.00%

1-Year Return

H02.SI
5.86%
STI Index
1.48%

3-Year Return

H02.SI
19.78%
STI Index
2.66%

5-Year Return

H02.SI
13.68%
STI Index
2.53%

Compare To: H02.SI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: H02.SI

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    2.18B

  • Enterprise Value

    -1.00B

  • Trailing P/E

    10.07

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.40

  • Price/Book (mrq)

    0.63

  • Enterprise Value/Revenue

    -4.31

  • Enterprise Value/EBITDA

    -4.22

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    93.32%

  • Return on Assets (ttm)

    1.10%

  • Return on Equity (ttm)

    6.17%

  • Revenue (ttm)

    232.06M

  • Net Income Avi to Common (ttm)

    216.57M

  • Diluted EPS (ttm)

    0.98

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    574.01M

  • Total Debt/Equity (mrq)

    0.82%

  • Levered Free Cash Flow (ttm)

    32.22M

Company Insights: H02.SI

People Also Watch